Published in Respir Med on June 01, 2002
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Can Respir J (2007) 4.27
Patient adherence in COPD. Thorax (2008) 2.85
Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD). Eur J Clin Pharmacol (2012) 1.25
Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain. Eur J Health Econ (2007) 1.13
The health economic impact of disease management programs for COPD: a systematic literature review and meta-analysis. BMC Pulm Med (2013) 1.05
Tackling COPD: a multicomponent disease driven by inflammation. MedGenMed (2006) 0.95
Estimating productivity costs using the friction cost approach in practice: a systematic review. Eur J Health Econ (2014) 0.85
Influence of a moderate physical activity intervention on red cell deformability in patients suffering from chronic obstructive pulmonary disease (COPD). Wien Med Wochenschr (2013) 0.75
Chronic obstructive pulmonary disease is associated with low levels of vitamin D. PLoS One (2012) 1.47
Explained variance for blood gases in a population with COPD. Clin Respir J (2011) 1.27
Hospital doctors' attitudes toward giving their patients smoking cessation help. Clin Respir J (2007) 1.01
Atopic and non-atopic asthma in a farming and a general population. Am J Ind Med (2004) 0.95
Increased prevalence of chronic obstructive pulmonary disease in a general population. Respir Med (2013) 0.91
Does smoking affect the outcome of patient education and self-management in asthmatics? Patient Educ Couns (2003) 0.90
Bronchodilator reversibility testing in an adult general population; the importance of smoking and anthropometrical variables on the response to a beta2-agonist. Pulm Pharmacol Ther (2005) 0.90
Case-control studies on risk factors for chronic obstructive pulmonary disease: how does the sampling of the cases and controls affect the results? Clin Respir J (2010) 0.86
Bronchodilator response to adrenergic beta2-agonists: relationship to symptoms in an adult community. Respir Med (2006) 0.84
HRQoL changes, mood disorders and satisfaction after treatment in an unselected population of patients with lung cancer. Clin Respir J (2010) 0.84
[Instructing patients in the correct use of inhalation devices]. Tidsskr Nor Laegeforen (2006) 0.83
Excessive costs of COPD in ever-smokers. A longitudinal community study. Respir Med (2010) 0.82
Predictors of health-related quality of life changes after lifestyle intervention in persons at risk of type 2 diabetes mellitus. Qual Life Res (2014) 0.81
Reference values for within-breath pulmonary impedance parameters in asymptomatic elderly. Clin Respir J (2012) 0.77
Relationships between hand-rolled cigarettes and primary lung cancer: a Norwegian experience. Clin Respir J (2009) 0.75
Aspects of healthcare utilisation in self-reported obstructive lung disease. Clin Respir J (2009) 0.75
[Genetics in chronic obstructive pulmonary disease]. Tidsskr Nor Laegeforen (2009) 0.75